Literature DB >> 32646349

Spanish Society of Hospital Pharmacy Position Statement on Telepharmacy: Recommendations for its implementation and development.

Ramón Morillo-Verdugo1, Luis Margusino-Framiñán2, Emilio Monte-Boquet3, Alberto Morell-Baladrón4, Dolores Barreda-Hernández5, Xosé Manuel Rey-Piñeiro6, Eva Negro-Vega7, Olga Delgado-Sánchez8.   

Abstract

The use of information and communication technologies have nowadays become  part and parcel of hospital pharmacy practice. Against this background, it is  hardly surprising that Telepharmacy has sparked the interest of a large number  of stakeholders. In this respect, the Spanish Society of Hospital Pharmacy has  developed a definition of the concept and outlined the conditions under which  Telepharmacy should operate. It has also shared its institutional stance on the  subject through a position statement that states that Telepharmacy is the  provision of pharmaceutical care at a distance through information and  communication technologies. Telepharmacy practice includes activities such as  therapeutic validation, drafting of clinical documents, provision of  pharmaceutical care, therapeutic follow-up, adherence monitoring, drug  education and information, coordination between healthcare providers and  evaluation of health outcomes. The clinical tasks performed as part of  Telepharmacy practice must adhere to a standardized procedure and revolve  around the patient's clinical record. Access to Telepharmacy must be provided without discrimination. The service comprises four main activities:  pharmacotherapeutic follow-up; patient and caregiver-directed education and information-dissemination; coordination with healthcare providers from the  same or different hospitals; and remote informed home drug delivery. Implementation of Telepharmacy requires an adjustment of human (training and capacity-building) and technological resources (validation, interoperability, confidentiality). It must also comply with the laws and regulations in force both  at a regional and a national level. Telepharmacy procedures must also be  adapted to the relevant ethical standards and codes of good practice.  Appropriate indicators must be used to evaluate the performance of  Telepharmacy and its impact on health outcomes. According to Spanish Society  of Hospital Pharmacy Telepharmacy is a necessary complementary tool to  provide specialized pharmaceutical care and thereby improve health outcomes  and maximize patient safety and satisfaction. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Year:  2020        PMID: 32646349     DOI: 10.7399/fh.11515

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  5 in total

1.  Pharmacists' Perspectives on the Use of Telepharmacy in Response to COVID-19 Pandemic in Ho Chi Minh City, Vietnam.

Authors:  Truong Van Dat; Trung Dinh Tran; Nguyen Thao My; Tran Thi Hong Nguyen; Nguyen Nhat Anh Quang; Mi Tra Vo Nguyen; Phuc Hong Ngoc Vo; Thanh-Tam Ho; Cuong Manh Nguyen; Tram Thi Ngoc Nguyen; Nguyen-Huu Lac-Thuy; Nga Tq Nguyen; Dieu-Thuong Thi Trinh; Hai-Yen Nguyen-Thi; Nguyen Tien Huy
Journal:  J Pharm Technol       Date:  2022-02-25

2.  Outpatients' Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project.

Authors:  Luis Margusino-Framiñán; Cecilia M Fernández-Llamazares; Eva Negro-Vega; Begoña Tortajada-Goitia; Garbiñe Lizeaga; Gabriel Mercadal-Orfila; Carmen Almeida-González; Ramón Morillo-Verdugo
Journal:  J Multidiscip Healthc       Date:  2021-12-31

3.  Implementation of a novel home delivery service during pandemic.

Authors:  Ana Peláez Bejarano; Pilar Villar Santos; Maria de Las Aguas Robustillo-Cortés; Ernesto Sánchez Gómez; Maria Dolores Santos Rubio
Journal:  Eur J Hosp Pharm       Date:  2020-10-28

Review 4.  Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale.

Authors:  Álvaro Narrillos-Moraza; Patricia Gómez-Martínez-Sagrera; Miguel Ángel Amor-García; Vicente Escudero-Vilaplana; Roberto Collado-Borrell; Cristina Villanueva-Bueno; Ignacio Gómez-Centurión; Ana Herranz-Alonso; María Sanjurjo-Sáez
Journal:  JMIR Mhealth Uhealth       Date:  2022-02-16       Impact factor: 4.947

5.  The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search.

Authors:  Rosa Romero-Jimenez; Vicente Escudero-Vilaplana; Esther Chamorro-De-Vega; Arantza Ais-Larisgoitia; Maria Elena Lobato Matilla; Ana Herranz-Alonso; Maria Sanjurjo
Journal:  J Med Internet Res       Date:  2022-03-04       Impact factor: 7.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.